ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

At A Glance: This Prescriber in 2012

Family Medicine

Self-Reported Primary Specialty

See Other Prescribers With This Specialty in This State »

19,496Medicare Part D Prescriptions Filled, Including Refills

Rank: 140 out of 3593

$572K Total Retail Price of All Prescriptions

Rank: 491 out of 3593

848 Patients Receiving at Least One Drug in Part D
92%Patients 65 Years and Older
11% Subsidized Claims for Low-Income Patients

How Does This Prescriber Compare to Peers?

In the same specialty and state. Caveats »

Drugs That Present Special Risks
Costs of Prescribing
Higher avg Average for
this specialty
in Florida
Lower avg

Schedule Two
Controlled Substances

N/A

Schedule Three
Controlled Substances

8% of this provider’s 848 patients filled at least one prescription for a schedule three drug, compared to an average of 9%.

Risky Drugs to Seniors

1% of this provider’s 18,413 prescriptions for patients 65 and older were for "potentially dangerous" drugs, compared to an average of 1%.

Brand Name Drugs

20% of this provider’s prescriptions were for brand-name drugs, compared to an average of 24%.

Prescription Price

$29 was the average price of a prescription from this provider, compared to $55 among peers.

Prescriptions per Patient

23 is the average number of prescriptions (including refills) per patient, compared to an average of 17.


Another View

This chart shows a different comparison of all providers in this specialty based on their mix of drugs and volume. Providers are grouped by similarity; those least like their peers are farthest to the right. Hover over the bars to see names of other prescribers.

← Prescribers more like their peers Prescribers less like their peers →
KEY: How to read this
chart

Fewer Prescribers
More Prescribers

This Prescriber
Hover to see more prescribers

This Prescriber's Drugs

The table below list this provider’s drugs, the number of prescriptions and how many went to seniors. Drugs are ranked by volume and compared with the rank for all providers in the same specialty and state.

Click to Filter by Category

Clear Filter


S2

A schedule two drug. More » Schedule two drugs have a high potential for abuse and severe dependence, according to the Drug Enforcement Administration.

S3

A schedule three drug. More » Schedule three drugs have potential for abuse and dependence, according to the Drug Enforcement Administration.

A

An antipsychotic drug. More » Antipsychotics are frequently given to dementia patients, though it increases their risk of death.

R

A risky drug for seniors. More » The American Geriatrics Society has said this drug is "potentially dangerous" for seniors and might be inappropriate.

10

This provider is among the top 10 prescribers of
this drug in the country.

This provider’s prescriptions for this drug were for more days than those of peers. More » Because of this, his or her prescription count may be lower.

This provider’s prescriptions for this drug were for fewer days than those of peers. More » Because of this, his or her prescription count may be higher.

This Drug's Rank
Drug Name Total Prescriptions Filled
Including Refills
Prescriptions
to 65+
Category For this Prescriber For All Prescribers in
This Specialty in Florida
LISINOPRIL 1,140 1,066 1 2
AMLODIPINE BESYLATE 996 927 2 3
ATORVASTATIN CALCIUM 911 869 3 15
LEVOXYL 811 786 4 111
OMEPRAZOLE 751 655 5 5
HYDROCHLOROTHIAZIDE 707 690 6 10
SIMVASTATIN 650 632 7 1
LOSARTAN POTASSIUM 627 619 8 14
METOPROLOL TARTRATE 625 614 9 8
ATENOLOL 558 520 10 11
WARFARIN SODIUM 477 474 11 18
FUROSEMIDE 434 416 12 9
LOVASTATIN 404 391 13 20
PRAVASTATIN SODIUM 361 346 14 13
K-TAB 361 349 10 14 217
METFORMIN HCL 348 338 16 6
ENALAPRIL MALEATE 339 316 17 38
DILTIAZEM 24HR CD 318 308 18 173
HYDROCODONE-ACETAMINOPHEN 269 248 S3 19 7
GLIMEPIRIDE 266 261 20 44
GEMFIBROZIL 264 252 21 88
ALENDRONATE SODIUM 235 233 22 22
CRESTOR 223 218 23 21
ALLOPURINOL 213 213 24 35
ZOLPIDEM TARTRATE 205 190 25 12
TRIAMTERENE-HCTZ 200 195 26 66
CLONIDINE HCL 196 182 27 41
ADACEL 183 174 28 394
ZETIA 171 171 29 110
GABAPENTIN 165 133 30 16
VENTOLIN HFA 161 146 31 80
GLIPIZIDE 146 146 32 40
TRAMADOL HCL 146 139 32 17
NIFEDIPINE ER 136 136 34 75
FOSINOPRIL SODIUM 123 123 35 235
TRICOR 122 109 36 130
AZITHROMYCIN 114 107 37 34
TAMSULOSIN HCL 113 113 38 33
ZOSTAVAX 111 106 39 168
SPIRIVA 110 99 40 87
SERTRALINE HCL 107 97 41 28
FLUTICASONE PROPIONATE 104 93 42 32
TERAZOSIN HCL 102 102 43 115
PREDNISONE 102 95 43 49
CLOPIDOGREL 98 98 45 30
OXYBUTYNIN CHLORIDE 97 94 46 104
RAMIPRIL 96 84 47 92
FINASTERIDE 93 93 48 79
RANITIDINE HCL 92 92 49 27
LANOXIN 90 90 50 223
CARVEDILOL 86 86 51 23
LEVOTHYROXINE SODIUM 85 83 52 4
BUPROPION HCL SR 85 75 52 207
FLUOXETINE HCL 83 75 54 60
FORTICAL 83 83 54 364
PAROXETINE HCL 81 72 56 62
PANTOPRAZOLE SODIUM 77 77 57 45
CITALOPRAM HBR 75 74 58 25
ESTRADIOL 74 63 R 59 174
VERAPAMIL ER 74 59 59 99
LEVEMIR 72 72 61 193
BENAZEPRIL HCL 69 56 62 69
CILOSTAZOL 66 66 63 163
PROPRANOLOL HCL 64 61 64 181
PLAVIX 60 60 65 42
SPIRONOLACTONE 58 45 66 86
GLYBURIDE 57 55 R 67 55
TRIAMCINOLONE ACETONIDE 57 52 67 119
DICLOFENAC SODIUM 54 54 69 74
CIPROFLOXACIN HCL 50 48 70 52
CYCLOBENZAPRINE HCL 50 36 R 70 72
About This Data

ProPublica obtained prescribing data from Medicare’s prescription drug benefit, known as Part D, under the Freedom of Information Act. The data for 2012 includes more than 1.2 billion prescriptions written by nearly 1.5 million doctors, nurses and other providers. This database lists about 382,000 of those providers who wrote 50 or more prescriptions for at least one drug that year. Almost three-fourths went to patients 65 and older; the rest were for disabled patients. Methodology »

Incorrect Info?

If you are a provider and you believe your address is incorrect, check the listing you created on the National Provider Identifier registry. If you change your listing, send a note to drugs@propublica.org and we will update your information. If you have other questions about this data, send a note to drugs@propublica.org.

Caveats
  • No comparisons are shown if 10 or fewer prescribers in the state share this specialty.
  • The list of top drugs includes only those for which this provider wrote 50 or more prescriptions, but all prescriptions are counted in the summary totals at the top.
  • The calculation of “Risky Drugs to Seniors” does not include drugs for which a provider wrote 11 or fewer prescriptions because Medicare redacted the information to protect patient privacy.
  • Comparisons do not take into account the medical conditions of patients. Medications for certain conditions do not have generic alternatives, so patients would receive more expensive brand name drugs.
  • This provider's address and specialty information was last updated on Feb. 23, 2011.
  • Comparisons are based on each provider’s current address, not necessarily where he or she worked during the time period covered in this database.